Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-25-020648
Filing Date
2025-04-29
Accepted
2025-04-29 16:01:28
Documents
25
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A dna-20250429.htm   iXBRL DEF 14A 681878
3 dna-20250429_g1.jpg GRAPHIC 246485
4 dna-20250429_g10.jpg GRAPHIC 296422
5 dna-20250429_g11.jpg GRAPHIC 439494
6 dna-20250429_g12.jpg GRAPHIC 250597
7 dna-20250429_g13.jpg GRAPHIC 444844
8 dna-20250429_g14.jpg GRAPHIC 227386
9 dna-20250429_g2.jpg GRAPHIC 156934
10 dna-20250429_g3.jpg GRAPHIC 31997
11 dna-20250429_g4.jpg GRAPHIC 49185
12 dna-20250429_g5.jpg GRAPHIC 14017
13 dna-20250429_g6.jpg GRAPHIC 212840
14 dna-20250429_g7.jpg GRAPHIC 14382
15 dna-20250429_g8.jpg GRAPHIC 171498
16 dna-20250429_g9.jpg GRAPHIC 384396
  Complete submission text file 0001628280-25-020648.txt   7958518

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20250429.xsd EX-101.SCH 935
27 EXTRACTED XBRL INSTANCE DOCUMENT dna-20250429_htm.xml XML 64824
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40097 | Film No.: 25886976
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)